No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:167203600-167218800 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
2 |
chr5:167209400-167214600 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
3 |
chr5:167210400-167212800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
4 |
chr5:167210800-167217200 |
Weak transcription |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
5 |
chr5:167210800-167225000 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
6 |
chr5:167211000-167214600 |
Weak transcription |
Fetal Muscle Leg |
muscle
|
7 |
chr5:167211200-167219200 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
8 |
chr5:167211400-167212600 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
9 |
chr5:167211400-167212600 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
10 |
chr5:167211400-167212600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
11 |
chr5:167211400-167213800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
12 |
chr5:167211600-167212600 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
13 |
chr5:167211600-167212600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
14 |
chr5:167211600-167212800 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
15 |
chr5:167211600-167212800 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
16 |
chr5:167211800-167214600 |
Weak transcription |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
17 |
chr5:167212200-167212600 |
Enhancers |
HSMM |
muscle
|
18 |
chr5:167212200-167213200 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
19 |
chr5:167212400-167212800 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
20 |
chr5:167212400-167214800 |
Enhancers |
Osteobl |
bone
|